Overexpression of FKBP51 in idiopathic myelofibrosis regulates the growth factor independence of megakaryocyte progenitors.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Blood

• Publication date

  2002-10-15

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/BLOOD-2002-02-0485PMID 12351405
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Determination of serine/threonine protein phosphatase type 2B PP2B in lymphocytes by HPLC.

  2003cited by this paper
• Activation of Nuclear Factor κb and bcl-x Survival Gene Expression by Nerve Growth Factor Requires Tyrosine Phosphorylation of IκBα

  2001cited by this paper
• Heat-shock protein 70 antagonizes apoptosis-inducing factor

  2001cited by this paper
• Elevated vascular endothelial growth factor (VEGF) serum levels in idiopathic myelofibrosis

  2001cited by this paper
• Cytogenetic findings and their clinical relevance in myelofibrosis with myeloid metaplasia

  2001cited by this paper
• Regulation of the Hsp90-binding immunophilin, cyclophilin 40, is mediated by multiple sites for GA-binding protein (GABP)

  2001cited by this paper
• Clinical and morphological criteria for the diagnosis of prefibrotic idiopathic (primary) myelofibrosis

  2001cited by this paper
• Functional analysis of the Hsp90-associated human peptidyl prolyl cis/trans isomerases FKBP51, FKBP52 and Cyp40.

  2001cited by this paper
• Overexpression of the FK506-binding immunophilin FKBP51 is the common cause of glucocorticoid resistance in three New World primates.

  2001cited by this paper
• Hsp90 is essential for the synthesis and subsequent membrane association, but not the maintenance, of the Src-kinase p56(lck).

  2000cited by this paper
• The NF-κB Cascade Is Important in Bcl-xL Expression and for the Anti-Apoptotic Effects of the CD28 Receptor in Primary Human CD4+ Lymphocytes1

  2000cited by this paper
• Myelofibrosis with myeloid metaplasia.

  2000cited by this paper
• NF-kappa B as a central mediator in the induction of TGF-beta in monocytes from patients with idiopathic myelofibrosis: an inflammatory response beyond the realm of homeostasis.

  2000cited by this paper
• Pathologic interaction between megakaryocytes and polymorphonuclear leukocytes in myelofibrosis.

  2000cited by this paper
• NF-κB as a Central Mediator in the Induction of TGF-β in Monocytes from Patients with Idiopathic Myelofibrosis: An Inflammatory Response Beyond the Realm of Homeostasis1

  2000cited by this paper
• Ca2+-induced apoptosis through calcineurin dephosphorylation of BAD.

  1999cited by this paper
• IGF-1 induces skeletal myocyte hypertrophy through calcineurin in association with GATA-2 and NF-ATc1

  1999cited by this paper
• Regulation of Angiotensin II-induced Phosphorylation of STAT3 in Vascular Smooth Muscle Cells*

  1999cited by this paper
• Initial (prefibrotic) stages of idiopathic (primary) myelofibrosis (IMF) – a clinicopathological study

  1999cited by this paper
• Clonality analysis using X-chromosome inactivation at the human androgen receptor gene (Humara). Evaluation of large cohorts of patients with chronic myeloproliferative diseases, secondary neutrophilia, and reactive thrombocytosis.

  1999cited by this paper
• Autonomous megakaryocyte growth in essential thrombocythemia and idiopathic myelofibrosis is not related to a c-mpl mutation or to an autocrine stimulation by Mpl-L.

  1999cited by this paper
• Multiple Components of the HSP90 Chaperone Complex Function in Regulation of Heat Shock Factor 1 In Vivo

  1999cited by this paper
• Inhibition of protein phosphatase 2A induces serine/threonine phosphorylation, subcellular redistribution, and functional inhibition of STAT3.

  1999cited by this paper
• Specific Binding of Tetratricopeptide Repeat Proteins to the C-terminal 12-kDa Domain of hsp90*

  1998cited by this paper
• Protein kinase C mediates the mitogenic action of thrombopoietin in c-Mpl-expressing UT-7 cells

  1998cited by this paper
• Adenovector-mediated expression of human thrombopoietin cDNA in immune-compromised mice: insights into the pathophysiology of osteomyelofibrosis.

  1998cited by this paper
• Protein kinase C mediates the mitogenic action of thrombopoietin in c-Mpl-expressing UT-7 cells.

  1998cited by this paper
• Expression of Bcl-x in erythroid precursors from patients with polycythemia vera.

  1998cited by this paper
• The role of transforming growth factor-beta in PEG-rHuMGDF-induced reversible myelofibrosis in rats.

  1997cited by this paper
• Thrombopoietin‐responsive essential thrombocythaemia with myelofibrosis

  1997cited by this paper
• Cyclosporin A interferes with the inducible degradation of NF-kappa B inhibitors, but not with the processing of p105/NF-kappa B1 in T cells.

  1997cited by this paper
• Cytogenetic abnormalities and their prognostic significance in idiopathic myelofibrosis: a study of 106 cases

  1997cited by this paper
• Allogeneic bone marrow transplantation for agnogenic myeloid metaplasia. French Society of Bone Marrow Transplantation.

  1997cited by this paper
• High thrombopoietin production by hematopoietic cells induces a fatal myeloproliferative syndrome in mice.

  1997cited by this paper
• The role of transforming growth factor‐β in PEG‐rHuMGDF‐induced reversible myelofibrosis in rats

  1997cited by this paper
• Tissue distribution and abundance of human FKBP51, and FK506-binding protein that can mediate calcineurin inhibition.

  1997cited by this paper
• Protein Phosphatase 5 Is a Major Component of Glucocorticoid Receptor·hsp90 Complexes with Properties of an FK506-binding Immunophilin*

  1997cited by this paper
• Allogeneic bone marrow transplantation for agnogenic myeloid metaplasia

  1997cited by this paper
• Cyclosporin A interferes with the inducible degradation of NF‐xB inhibitors, but not with the processing of p105/NF‐xB1 in T cells

  1997cited by this paper
• A model of myelofibrosis and osteosclerosis in mice induced by overexpressing thrombopoietin (mpl ligand): reversal of disease by bone marrow transplantation.

  1996cited by this paper
• Apoptosis induced by inhibitors of the plasma membrane NADH-oxidase involves Bcl-2 and calcineurin.

  1996cited by this paper
• Deposition of transforming growth factor-beta in the marrow in myelofibrosis, and the intracellular localization and secretion of TGF-beta by leukemic cells.

  1995cited by this paper
• FKBP51, a novel T-cell-specific immunophilin capable of calcineurin inhibition

  1995cited by this paper
• Primary myelofibrosis: A detailed statistical analysis of the clinicopathological variables influencing survival

  1994cited by this paper
• Calcineurin acts in synergy with PMA to inactivate I kappa B/MAD3, an inhibitor of NF‐kappa B.

  1994cited by this paper
• Transforming growth factor‐β and megakaryocytes in the pathogenesis of idiopathic myelofibrosis

  1994cited by this paper
• Calcineurin activates transcription from the GM-CSF promoter in synergy with either protein kinase C or NF-kappa B/AP-1 in T cells.

  1994cited by this paper
• Circulating megakaryocyte progenitors in myeloproliferative disorders are hypersensitive to interleukin‐3

  1993cited by this paper
• Raf exists in a native heterocomplex with hsp90 and p50 that can be reconstituted in a cell-free system.

  1993cited by this paper
• The frequency and significance of megakaryocytic emperipolesis in myeloproliferative and reactive states

  1992cited by this paper
• Detection of platelet-specific protein mRNAs in different megakaryoblasts using the reverse transcriptase polymerase chain reaction.

  1992cited by this paper
• Calcineurin phosphatase activity in T lymphocytes is inhibited by FK 506 and cyclosporin A.

  1992cited by this paper
• Characterization of high molecular weight FK-506 binding activities reveals a novel FK-506-binding protein as well as a protein complex.

  1992cited by this paper
• Enhanced hematopoietic growth factor production in an experimental myeloproliferative syndrome.

  1992cited by this paper
• Increased intraplatelet levels of platelet‐derived growth factor and transforming growth factor‐β in patients with myelofibrosis with myeloid metaplasia

  1991cited by this paper
• Establishment and characterization of a human leukemic cell line with megakaryocytic features: dependency on granulocyte-macrophage colony-stimulating factor, interleukin 3, or erythropoietin for growth and survival.

  1991cited by this paper
• Platelet derived growth factor messenger RNA is increased in bone marrow megakaryocytes in patients with myeloproliferative disorders

  1990cited by this paper
• Pro-megakaryoblasts in bone marrow tissue from patients with primary (idiopathic) osteo-myelofibrosis (agnogenic myeloid metaplasia). An immunomorphometric study on trephine biopsies.

  1990cited by this paper
• PROGNOSTIC CLASSIFICATION OF MYELOFIBROSIS WITH MYELOID METAPLASIA

  1989cited by this paper
• Endogenous megakaryocyte colonies from peripheral blood in precursor cell cultures of patients with myeloproliferative disorders

  1989cited by this paper
• Megakaryocyte colony formation in chronic myeloid leukemia and myelofibrosis.

  1988cited by this paper
• Immunohistochemical study of basement membrane proteins and type III procollagen in myelofibrosis

  1986cited by this paper
• Platelet factor‐4 excretion in myeloproliferative disease: implications for the aetiology of myelofibrosis

  1984cited by this paper
• Agnogenic myeloid metaplasia: a clonal proliferation of hematopoietic stem cells with secondary myelofibrosis.

  1978cited by this paper

• A novel application of XPO1 inhibition for the treatment of myelofibrosis

  2024cites this paper
• Scaffold proteins of cancer signaling networks: The paradigm of FK506 binding protein 51 (FKBP51) supporting tumor intrinsic properties and immune escape

  2023cites this paper
• FKBP51 plays an essential role in Akt ubiquitination that requires Hsp90 and PHLPP

  2023cites this paper
• Functions of the Hsp90-Binding FKBP Immunophilins.

  2023cites this paper
• The emerging importance of immunophilins in fibrosis development

  2022cites this paper
• Deregulated calcium signaling in blood cancer: Underlying mechanisms and therapeutic potential

  2022cites this paper
• Central stress processing, T-cell responsivity to stress hormones and disease severity in multiple sclerosis

  2022cites this paper
• Post-translational modifications and stress adaptation: the paradigm of FKBP51

  2020cites this paper
• Expression of FK506‐binding protein 51 (FKBP51) in Mycosis fungoides

  2018cites this paper
• The FKBP51 Glucocorticoid Receptor Co-Chaperone: Regulation, Function, and Implications in Health and Disease

  2017cites this paper
• Anno Accademico 2015 – 2016

  2017cites this paper
• Biological relevance of Hsp90‐binding immunophilins in cancer development and treatment

  2016cites this paper
• Myeloproliferative Neoplasms With Calreticulin Mutations Exhibit Distinctive Morphologic Features.

  2016cites this paper
• Transcriptional Regulation of Platelet Formation: Harnessing the Complexity for Efficient Platelet Production In Vitro

  2016cites this paper
• Molecular Aspects of FKBP51 that Enable Melanoma Dissemination.

  2015cites this paper
• Pleiotropic roles in cancer biology for multifaceted proteins FKBPs.

  2015cites this paper
• PRİMER MİYELOFİBROZİS: PATOGENEZ, TEŞHİS VE TEDAVİDE GÜNCEL BİLGİLER

  2015cites this paper
• FKBP51 employs both scaffold and isomerase functions to promote NF-κB activation in melanoma

  2015cites this paper
• Functions of the Hsp90-binding FKBP immunophilins.

  2015cites this paper
• The Emerging Role of TPR-Domain Immunophilins in the Mechanism of Action of Steroid Receptors

  2014cites this paper
• Molecular chaperone activity and biological regulatory actions of the TPR-domain immunophilins FKBP51 and FKBP52.

  2014cites this paper
• Mutated calreticulin retains structurally disordered C terminus that cannot bind Ca2+: some mechanistic and therapeutic implications

  2014cites this paper
• Association of long-term tacrolimus (FK506) therapy with abnormal megakaryocytosis, bone marrow fibrosis, and dyserythropoiesis

  2014cites this paper
• The calcineurin-NFAT pathway negatively regulates megakaryopoiesis.

  2013cites this paper
• The Large Immunophilin FKBP 51 in Apoptosis and Cancer

  2013cites this paper
• The Prospect of FKBP51 as a Drug Target

  2012cites this paper
• Popeye proteins: muscle for the aging sinus node.

  2012cites this paper
• Increased dosage of the chromosome 21 ortholog Dyrk1a promotes megakaryoblastic leukemia in a murine model of Down syndrome.

  2012cites this paper
• DYRK1A in Down syndrome: an oncogene or tumor suppressor?

  2012cites this paper
• Immunophilins and thrombotic disorders.

  2011cites this paper
• Rôle du couple Flt3-ligand/Flt3 et de l'activation des "Mitogen-activated protein kinases" p38 dans la dysmégacaryopoïèse des patients atteints de myélofibrose primitive

  2011cites this paper
• In Vitro Megakaryocyte Differentiation and Proplatelet Formation in Ph-Negative Classical Myeloproliferative Neoplasms: Distinct Patterns in the Different Clinical Phenotypes

  2011cites this paper
• The Emerging Role of Large Immunophilin FK506 Binding Protein 51 in Cancer

  2011cites this paper
• FKBP51 protects 661w cell culture from staurosporine-induced apoptosis

  2011influential citation
• Immunohistochemical analysis of FKBP51 in human cancers.

  2011cites this paper
• FKBP51 and the NF-κB regulatory pathway in cancer.

  2011cites this paper
• Analysis of the effects of siRNA-mediated knock-down of glucocorticoid target genes in primary erythroid progenitor cells

  2011influential citation
• Intracranial self‐stimulation induces expression of learning and memory‐related genes in rat amygdala

  2011cites this paper
• FK506-binding protein 51 is a possible novel tumoral marker

  2010cites this paper
• [JAK2-V617F mutation in patients with myeloproliferative neoplasms: association with FLT3-ITD mutation].

  2010cites this paper
• Open letter to the Editor

  2010cites this paper
• Intracranial self-stimulation to the lateral hypothalamus, a memory improving treatment, results in hippocampal changes in gene expression.

  2009cites this paper
• FKBP51 and Cyp40 are Positive Regulators of Androgen-dependent Prostate Cancer Cell Growth and the Targets of FK506 and Cyclosporin A

  2009cites this paper
• Modulation of glucocorticoid receptor nuclear translocation in neurons by immunophilins FKBP51 and FKBP52: implications for major depressive disorder.

  2009cites this paper
• Pathogenetic insight and prognostic information from standard and molecular cytogenetic studies in the BCR-ABL-negative myeloproliferative neoplasms (MPNs)

  2008cites this paper
• Untersuchung des Expressionsmusters und der Neuropathologie konditionaler Mausmodelle des Morbus Parkinson

  2008cites this paper
• FKBP51 Expressed by Both Normal Epithelial Cells and Adenocarcinoma of Colon Suppresses Proliferation of Colorectal Adenocarcinoma

  2008cites this paper
• Gemcitabine and cytosine arabinoside cytotoxicity: association with lymphoblastoid cell expression.

  2008cites this paper
• IMMUNOPHILINS FKBP52 AND FKBP51 MODULATE GLUCOCORTICOID RECEPTOR DISTRIBUTION IN NEURONS AND ARE ALTERED IN HIV AND MAJOR DEPRESSIVE DISORDER

  2008cites this paper
• HEREDITARY AND FAMILIAL SYNDROMES OF BONE AND BLOOD. GENETIC PATHWAYS, DIAGNOSTIC PITFALLS

  2007cites this paper
• Biology and treatment of primary myelofibrosis.

  2007cites this paper
• Calcineurin Regulation in Fungi and Beyond

  2007cites this paper
• Chronic Idiopathic Myelofibrosis

  2007cites this paper
• Myelofibrosis with myeloid metaplasia

  2006cites this paper
• Grade of bone marrow fibrosis is associated with relevant hematological findings—a clinicopathological study on 865 patients with chronic idiopathic myelofibrosis

  2006cites this paper
• The JAK2V617F tyrosine kinase mutation in myeloproliferative disorders: Summary of published literature and a perspective

  2006cites this paper
• Breakpoint Associated with a novel 2.3 Mb deletion in the VCFS region of 22q11 and the role of Alu (SINE) in recurring microdeletions

  2006cites this paper
• cis-Regulatory sequences of the genes involved in apoptosis, cell growth, and proliferation may provide a target for some of the effects of acute ethanol exposure.

  2006cites this paper
• Immunophilins: for the love of proteins

  2006cites this paper
• Genomic gain at 6p21: a new cryptic molecular rearrangement in secondary myelodysplastic syndrome and acute myeloid leukemia

  2006cites this paper
• Review Immunophilins: for the love of proteins

  2006cites this paper
• Cryptic 6p21.3 duplications and triplication involving HMGA1 partially masked by add 6p in four cases of myelodysplasia.

  2006cites this paper
• Cytogenetic and molecular genetic abnormalities in agnogenic myeloid metaplasia.

  2005cites this paper
• Importance of Plasma Matrix Metalloproteinases (MMP) and Tissue Inhibitors of Metalloproteinase (TIMP) in development of fibrosis in agnogenic myeloid metaplasia

  2005cites this paper
• Pathogenesis of myelofibrosis with myeloid metaplasia.

  2005cites this paper
• Stem cell dysregulation in myelofibrosis with myeloid metaplasia: current data on growth factor and transcription factor involvement.

  2005cites this paper
• Der(6)t(1;6)(q21–23;p21.3): a specific cytogenetic abnormality in myelofibrosis with myeloid metaplasia

  2005cites this paper
• mRNA expression levels of (co)chaperone molecules of the glucocorticoid receptor are not involved in glucocorticoid resistance in pediatric ALL

  2005cites this paper
• Role for the nuclear factor kappaB pathway in transforming growth factor-beta1 production in idiopathic myelofibrosis: possible relationship with FK506 binding protein 51 overexpression.

  2005cites this paper
• Detection of Aberrant Gene Expression in CD34+ Hematopoietic Stem Cells from Patients with Agnogenic Myeloid Metaplasia Using Oligonucleotide Microarrays

  2005cites this paper
• Surgical and radiotherapeutic approaches for myelofibrosis with myeloid metaplasia.

  2005cites this paper
• Molecular pathogenesis of Philadelphia chromosome negative myeloproliferative disorders.

  2005cites this paper
• Conventional and new treatment options for myelofibrosis with myeloid metaplasia.

  2005cites this paper
• Widespread occurrence of the JAK2 V617F mutation in chronic myeloproliferative disorders.

  2005influential citation
• Pathophysiology and Stem Cell Biology in Myelofibrosis with Myeloid Metaplasia

  2004cites this paper
• Transplant strategies for idiopathic myelofibrosis.

  2004cites this paper
• Gene expression profiling of normal and malignant CD34-derived megakaryocytic cells.

  2004cites this paper
• Chronic myelogenous leukemia and myeloproliferative disease.

  2004cites this paper
• Constitutive expression of the FK506 binding protein 51 (FKBP51) in bone marrow cells and megakaryocytes derived from idiopathic myelofibrosis and non‐neoplastic haematopoiesis

  2004cites this paper
• Intronic hormone response elements mediate regulation of FKBP5 by progestins and glucocorticoids

  2004cites this paper
• Die Funktion der Cochaperone FKBP51, FKBP52 und p23 bei der Signaltransduktion der Corticoidrezeptoren

  2004cites this paper
• Spontaneous STAT5 activation induces growth factor independence in idiopathic myelofibrosis: possible relationship with FKBP51 overexpression.

  2003cites this paper
• Myelodysplastic syndromes, chronic myeloproliferative diseases, and myelodysplastic/myeloproliferative diseases.

  2003cites this paper